2025 Preliminary Results: Sales Growth Continues, Net Profit Declines
-
Sales: 257,829 million KRW (+15.9% YoY)
-
Operating profit: 33,304 million KRW (-7.1% YoY)
-
Net profit: 28,753 million KRW (-34.6% YoY)
-
Net profit decline due to one-time SG&A expenses and base effect from prior year derivative gains
-
Total assets: 318,633 million, liabilities: 97,908 million, equity: 220,725 million
-
Separate: sales 234,014 million, operating profit 31,201 million, net profit 26,742 million
-
Unaudited, subject to change
KOSPI Filing Information
-
Filing: Change in Sales or Profit Structure of 30% (15% for Large Corporations) or More
-
Company: JW LIFESCIENCE (234080)
-
Submission: JW LIFESCIENCE CORPORATION
-
Receipt: 02-02-2026
-
Under KRX KOSPI Market Division